With the analysis among 2,366 patents, we discovered top 385 key players by total patent application. Smithkline Beckman Corp, Euro-Celtique SA, Novartis AG are dominant in this area. They take 14.96% of the total patent filing.
Pennsylvania, United States
Patent: 138
Luxembourg, Luxembourg
Patent: 122
Basel-Stadt, Switzerland
Patent: 94
Taisho Pharmaceutical Co., Ltd.
Tokyo-to, Japan
Patent: 85
Merck Sharp & Dohme Corp.
New Jersey, United States
Patent: 71
F. Hoffmann-La Roche Ltd.
Manchester, United Kingdom
Patent: 43
Hessen, Germany
Patent: 41
AstraZeneca Pharmaceutical Co., Ltd.
Jiangsu Sheng, China
Patent: 41
ACADIA Pharmaceuticals, Inc.
California, United States
Patent: 37
With the analysis among 60 patents, we discovered top 11 start-ups by total patent application. Galvanize Therapeutics, Inc., Prilenia Therapeutics Development Ltd., Sinopia Biosciences, Inc. are active in this area.
Galvanize Therapeutics, Inc.
California, United States
Patent: 13
Prilenia Therapeutics Development Ltd.
Sinopia Biosciences, Inc.
California, United States
Patent: 9
Nacuity Pharmaceuticals, Inc.
Texas, United States
Patent: 8
California, United States
Patent: 7
ReCode Therapeutics, Inc.
Texas, United States
Patent: 3
Institut National de la Santé et de la Recherche Médicale
Illinois, United States
Patent: 2
New Jersey, United States
Patent: 2
Shanghai Shi, China
Patent: 1
With the analysis among related 679 patents applied in the last 5 years. We discover 283 most active companies in this area. The fast-growing Merck Sharp & Dohme Corp., Novartis AG, Neurocrine Biosciences, Inc. take 10.16% of patent filing during this period.
Merck Sharp & Dohme Corp.
New Jersey, United States
Patent: 29
Basel-Stadt, Switzerland
Patent: 22
Neurocrine Biosciences, Inc.
California, United States
Patent: 18
Auspex Pharmaceuticals, Inc.
California, United States
Patent: 16
New Jersey, United States
Patent: 16
Sumitomo Pharmaceuticals Co., Ltd.
Osaka-fu, Japan
Patent: 15
Galvanize Therapeutics, Inc.
California, United States
Patent: 11
Prilenia Therapeutics Development Ltd.
With the analysis among related 679 patents in last 5 years, we discover 221 new entrants. Peptron, Inc., Nacuity Pharmaceuticals, Inc., Zhejiang University are the most active new entrants in this area.
Nacuity Pharmaceuticals, Inc.
Texas, United States
Patent: 8
Zhejiang Sheng, China
Patent: 8
Foshan Ruijian Sports Equipment Co., Ltd.
Guangdong Sheng, China
Patent: 8
University of Santiago de Compostela
Tongren Polytechnic College
Guizhou Sheng, China
Patent: 7
Pennsylvania, United States
Patent: 7
Biohaven Therapeutics Ltd.
British Virgin Islands
Patent: 6
Assistance Publique des Hôpitaux de Paris SA
Chrono Therapeutics, Inc.
California, United States
Patent: 5
With the analysis among 376 patents, we discovered top 120 universities and scientific research institutions by total patent application. Rutgers State University of New Jersey, Drexel University, The University of North Carolina at Chapel Hill are dominant in this area. They take 9.84% of the total patent filing.
Rutgers State University of New Jersey
New Mexico, United States
Patent: 18
Pennsylvania, United States
Patent: 10
The University of North Carolina at Chapel Hill
North Carolina, United States
Patent: 8
Zhejiang Sheng, China
Patent: 8
University of Santiago de Compostela
Guangdong Sheng, China
Patent: 6
University of Shanghai for Science & Technology
Shanghai Shi, China
Patent: 6
Illinois, United States
Patent: 5
University of Medicine & Dentistry of New Jersey
New Jersey, United States
Patent: 5
Hangzhou Dianzi University
Zhejiang Sheng, China
Patent: 5